Medicure Inc. (MPH.V)
CAD 0.9
(0.0%)
CAD 0.9
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 28.05 Million CAD | -6.15% |
| 2022 | 29.89 Million CAD | 5.25% |
| 2021 | 28.4 Million CAD | -16.58% |
| 2020 | 34.05 Million CAD | -19.46% |
| 2019 | 42.28 Million CAD | -59.25% |
| 2018 | 103.76 Million CAD | -19.52% |
| 2017 | 128.93 Million CAD | -39.96% |
| 2016 | 214.72 Million CAD | 910.15% |
| 2015 | 21.25 Million CAD | 224.01% |
| 2014 | 6.56 Million CAD | 0.0% |
| 2012 | 3.42 Million CAD | -27.82% |
| 2011 | 4.74 Million CAD | -8.32% |
| 2010 | 5.17 Million CAD | -13.38% |
| 2009 | 5.97 Million CAD | -37.45% |
| 2008 | 9.54 Million CAD | -72.56% |
| 2007 | 34.8 Million CAD | -41.78% |
| 2006 | 59.78 Million CAD | 54.03% |
| 2005 | 38.81 Million CAD | 285.33% |
| 2004 | 10.07 Million CAD | -55.0% |
| 2003 | 22.38 Million CAD | 322.69% |
| 2002 | 5.29 Million CAD | -43.52% |
| 2001 | 9.37 Million CAD | 112.05% |
| 2000 | 4.42 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 28.67 Million CAD | 2.19% |
| 2024 Q2 | 28.23 Million CAD | -1.52% |
| 2023 Q4 | 28.05 Million CAD | -2.72% |
| 2023 Q2 | 29.2 Million CAD | -0.52% |
| 2023 FY | 28.05 Million CAD | -6.15% |
| 2023 Q3 | 28.84 Million CAD | -1.24% |
| 2023 Q1 | 29.36 Million CAD | -1.8% |
| 2022 Q3 | 29.96 Million CAD | 0.17% |
| 2022 Q4 | 29.89 Million CAD | -0.21% |
| 2022 FY | 29.89 Million CAD | 5.25% |
| 2022 Q1 | 28.22 Million CAD | -0.65% |
| 2022 Q2 | 29.9 Million CAD | 5.97% |
| 2021 Q3 | 30.17 Million CAD | -2.43% |
| 2021 Q1 | 31.84 Million CAD | -6.5% |
| 2021 Q4 | 28.4 Million CAD | -5.86% |
| 2021 FY | 28.4 Million CAD | -16.58% |
| 2021 Q2 | 30.92 Million CAD | -2.87% |
| 2020 Q2 | 37.13 Million CAD | -14.56% |
| 2020 FY | 34.05 Million CAD | -19.46% |
| 2020 Q3 | 34.64 Million CAD | -6.71% |
| 2020 Q1 | 43.46 Million CAD | 2.79% |
| 2020 Q4 | 34.05 Million CAD | -1.71% |
| 2019 FY | 42.28 Million CAD | -59.25% |
| 2019 Q2 | 91.64 Million CAD | -6.49% |
| 2019 Q3 | 91.78 Million CAD | 0.15% |
| 2019 Q1 | 98 Million CAD | -5.55% |
| 2019 Q4 | 42.28 Million CAD | -53.93% |
| 2018 Q1 | 99.05 Million CAD | -23.18% |
| 2018 FY | 103.76 Million CAD | -19.52% |
| 2018 Q4 | 103.76 Million CAD | 1.13% |
| 2018 Q3 | 102.6 Million CAD | -3.34% |
| 2018 Q2 | 106.14 Million CAD | 7.17% |
| 2017 FY | 128.93 Million CAD | -39.96% |
| 2017 Q4 | 128.93 Million CAD | -28.01% |
| 2017 Q3 | 179.09 Million CAD | -5.91% |
| 2017 Q2 | 190.34 Million CAD | 0.73% |
| 2017 Q1 | 188.97 Million CAD | -11.99% |
| 2016 FY | 214.72 Million CAD | 910.15% |
| 2016 Q2 | 19.36 Million CAD | 7.14% |
| 2016 Q1 | 18.07 Million CAD | -14.96% |
| 2016 Q3 | 21.63 Million CAD | 11.73% |
| 2016 Q4 | 214.72 Million CAD | 892.29% |
| 2015 Q4 | 21.25 Million CAD | 75.07% |
| 2015 Q1 | 7.76 Million CAD | 0.0% |
| 2015 Q3 | 12.14 Million CAD | 1.01% |
| 2015 FY | 21.25 Million CAD | 224.01% |
| 2015 Q2 | 12.02 Million CAD | 54.9% |
| 2014 FY | 6.56 Million CAD | 0.0% |
| 2014 Q1 | 4.06 Million CAD | 24.71% |
| 2014 Q2 | 3.6 Million CAD | -11.16% |
| 2014 Q3 | 5.6 Million CAD | 55.38% |
| 2013 Q1 | 3.61 Million CAD | -6.85% |
| 2013 Q2 | 3.42 Million CAD | -5.27% |
| 2013 Q3 | 3.27 Million CAD | -4.37% |
| 2013 Q4 | 3.25 Million CAD | -0.56% |
| 2012 Q2 | 4.74 Million CAD | -13.41% |
| 2012 FY | 3.42 Million CAD | -27.82% |
| 2012 Q4 | 3.88 Million CAD | -5.6% |
| 2012 Q3 | 4.11 Million CAD | -13.35% |
| 2012 Q1 | 5.47 Million CAD | -15.85% |
| 2011 FY | 4.74 Million CAD | -8.32% |
| 2011 Q4 | 6.51 Million CAD | 11.94% |
| 2011 Q3 | 5.81 Million CAD | 12.41% |
| 2011 Q2 | 5.17 Million CAD | -9.65% |
| 2011 Q1 | 5.72 Million CAD | 4.12% |
| 2010 Q1 | 6.47 Million CAD | -17.54% |
| 2010 Q2 | 5.97 Million CAD | -7.73% |
| 2010 Q3 | 5.6 Million CAD | -6.24% |
| 2010 Q4 | 5.5 Million CAD | -1.78% |
| 2010 FY | 5.17 Million CAD | -13.38% |
| 2009 Q1 | 13.6 Million CAD | -15.27% |
| 2009 Q3 | 8.53 Million CAD | -10.64% |
| 2009 Q2 | 9.54 Million CAD | -29.81% |
| 2009 Q4 | 7.85 Million CAD | -8.0% |
| 2009 FY | 5.97 Million CAD | -37.45% |
| 2008 Q4 | 16.05 Million CAD | -48.6% |
| 2008 Q3 | 31.24 Million CAD | -10.23% |
| 2008 Q2 | 34.8 Million CAD | -12.55% |
| 2008 Q1 | 39.8 Million CAD | -37.78% |
| 2008 FY | 9.54 Million CAD | -72.56% |
| 2007 Q3 | 44.82 Million CAD | -25.02% |
| 2007 Q1 | 73.36 Million CAD | 44.75% |
| 2007 FY | 34.8 Million CAD | -41.78% |
| 2007 Q4 | 63.96 Million CAD | 42.71% |
| 2007 Q2 | 59.78 Million CAD | -18.51% |
| 2006 Q1 | 14.87 Million CAD | 136.8% |
| 2006 Q4 | 50.68 Million CAD | -6.64% |
| 2006 Q2 | 38.81 Million CAD | 160.91% |
| 2006 FY | 59.78 Million CAD | 54.03% |
| 2006 Q3 | 54.29 Million CAD | 39.88% |
| 2005 FY | 38.81 Million CAD | 285.33% |
| 2005 Q3 | 9.89 Million CAD | -1.81% |
| 2005 Q1 | 14.53 Million CAD | -15.27% |
| 2005 Q2 | 10.07 Million CAD | -30.72% |
| 2005 Q4 | 6.28 Million CAD | -36.48% |
| 2004 Q3 | 20.33 Million CAD | -9.17% |
| 2004 Q2 | 22.38 Million CAD | -6.58% |
| 2004 FY | 10.07 Million CAD | -55.0% |
| 2004 Q1 | 23.96 Million CAD | 103.64% |
| 2004 Q4 | 17.15 Million CAD | -15.61% |
| 2003 Q2 | 5.29 Million CAD | -15.86% |
| 2003 Q1 | 6.29 Million CAD | -8.72% |
| 2003 FY | 22.38 Million CAD | 322.69% |
| 2003 Q3 | 11.53 Million CAD | 117.83% |
| 2003 Q4 | 11.76 Million CAD | 2.0% |
| 2002 FY | 5.29 Million CAD | -43.52% |
| 2002 Q4 | 6.89 Million CAD | -14.93% |
| 2002 Q3 | 8.1 Million CAD | 0.0% |
| 2001 FY | 9.37 Million CAD | 112.05% |
| 2000 FY | 4.42 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 1.08 Million CAD | -2483.171% |
| CanadaBis Capital Inc. | 22.96 Million CAD | -22.192% |
| Decibel Cannabis Company Inc. | 142.98 Million CAD | 80.377% |
| Delivra Health Brands Inc. | 10.05 Million CAD | -179.138% |
| Entourage Health Corp. | 31.39 Million CAD | 10.619% |
| Lifeist Wellness Inc. | 13.39 Million CAD | -109.409% |
| Cannara Biotech Inc. | 141.52 Million CAD | 80.173% |
| PharmaCielo Ltd. | 22.28 Million CAD | -25.885% |
| Rubicon Organics Inc. | 54.89 Million CAD | 48.882% |
| BioSyent Inc. | 41.52 Million CAD | 32.435% |
| Voyageur Pharmaceuticals Ltd. | 2.16 Million CAD | -1196.829% |